Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.844 SEK | -9.16% | -3.66% | +4.06% |
04-29 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 | |
04-29 | Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina | CI |
Business Summary
Number of employees: 11
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Non-invasive Blood Tests
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +35.66% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
59.1
%
| 1 | 59.2 % | 1 | 59.1 % | +35.40% |
United States
40.9
%
| 0 | 0.0 % | 0 | 40.9 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 31/03/22 | |
Karl Stone
COO | Chief Operating Officer | 61 | 28/02/23 |
Chief Tech/Sci/R&D Officer | - | 31/01/23 | |
Linda Mellby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Thomas C. King
CTO | Chief Tech/Sci/R&D Officer | 66 | 31/12/16 |
Chief Tech/Sci/R&D Officer | 71 | 31/12/12 | |
Philipp Mathieu
BRD | Director/Board Member | 46 | 19/01/22 |
Tobias Bülow
IRC | Investor Relations Contact | - | 14/01/22 |
Cindy Callahan
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 08/12/16 | |
Peter Andersen
CHM | Chairman | 67 | 31/12/19 |
Michael Löfman
BRD | Director/Board Member | - | 21/05/23 |
Martin Møller
BRD | Director/Board Member | 49 | 31/12/20 |
Eric Krafft
BRD | Director/Board Member | 49 | 31/03/22 |
Philipp Mathieu
BRD | Director/Board Member | 46 | 19/01/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,287,498 | 34,200,305 ( 75.52 %) | 0 | 75.52 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.06% | 8.38M | |
-15.52% | 18.54B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+25.21% | 1.23B | |
-13.90% | 989M | |
-21.76% | 896M | |
-5.01% | 744M | |
-19.85% | 673M | |
+7.31% | 490M |
- Stock Market
- Equities
- IMMNOV Stock
- Company Immunovia AB